Use of a thrombin inhibitor processes to control wound healing processes within the body by inhibiting or preventing adhesion related to fibrin and inhibiting or preventing the formation of scar tissue and pharmaceuticals

摘要

There is provided the use of a thrombin inhibitor in the manufacture of a product for use in the control of wound healing processes within the body, in particular, the inhibition or prevention of fibrin-related adhesion and/or scar tissue formation, as well as products for use in the control of wound healing processes within the body comprising polysaccharides (e.g., chitosans) and low molecular weight peptide-based thrombin inhibitors.